• Home   ›
  •   Global Tenders   › Tender Reference No: 104392383

    • Tenders Are Invited For Purchase Of The Drug Ocrelizumab (40 Mg/Ml)

    Tender Detail

    104392383
    You can view only after subscription.
    49/25.
    Self-Funded
    Tenders Are Invited For Purchase Of The Drug Ocrelizumab (40 Mg/Ml)
    NCB
    You can view only after subscription.
    Eastern Europe
    Balkans,European Union
    27-11-2025

    Work Detail

    Purchase of the drug ocrelizumab (40 mg/ml)

    Key Value

    Tender Value
    1,12,499 - HRK

    Attachment

    FileName File Description
    Global Tender Document 21cc5121-53c5-4cb9-8222-caa80353c8a2.html
    Attachments
    Click Here To Download
    Tender Documents

    Additional Details Available on Click
    ✓ Tendering Authority
    ✓ Publication Document
    (Tender Document / Tender Notice )
    Disclaimer :
    We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
    Tell us about your Product / Services,
    We will Find Tenders for you
    Cnet Technologies

    We are a group of professionals specializing in custom software development, web development, mobile app development, IOT base solutions, web design, graphics & Enterprise solutions provid.

    About Us

    Services

    Browse Tenders

    For Sales Inquiry

    Connect With Us

    Copyright © 2025 · All Rights Reserved. Terms of Usage | Privacy Policy

    For Tender Information Services Visit : TenderDetail